My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 113

    1.

    Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes.

    Abdi R, Fiorina P, Adra CN, Atkinson M, Sayegh MH.

    Diabetes. 2008 Jul;57(7):1759-67. Review.PMID: 18586907 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Immunomodulatory properties of mesenchymal stromal cells.

    Nauta AJ, Fibbe WE.

    Blood. 2007 Nov 15;110(10):3499-506. Epub 2007 Jul 30. Review.PMID: 17664353 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    [Mesenchymal stem cells and the immune system--immunosuppression without drugs?]

    Kiss J, Urbán VS, Dudics V, Vas V, Uher F.

    Orv Hetil. 2008 Feb 24;149(8):339-46. Review. Hungarian. PMID: 18281229 [PubMed - indexed for MEDLINE]Related articles

    4.

    Immunoregulatory function of mesenchymal stem cells.

    Uccelli A, Moretta L, Pistoia V.

    Eur J Immunol. 2006 Oct;36(10):2566-73. Review.PMID: 17013987 [PubMed - indexed for MEDLINE]Related articles

    5.

    Mesenchymal stem cells in immunoregulation.

    Chen X, Armstrong MA, Li G.

    Immunol Cell Biol. 2006 Oct;84(5):413-21. Epub 2006 Jul 20. Review.PMID: 16869941 [PubMed - indexed for MEDLINE]Related articles

    6.

    Mesenchymal stem cells: immunobiology and therapeutic potential in kidney disease.

    McTaggart SJ, Atkinson K.

    Nephrology (Carlton). 2007 Feb;12(1):44-52. Review.PMID: 17295660 [PubMed - indexed for MEDLINE]Related articles

    7.

    Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

    Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, Obert L, Borg C, Saas P, Tiberghien P, Rouas-Freiss N, Carosella ED, Deschaseaux F.

    Stem Cells. 2008 Jan;26(1):212-22. Epub 2007 Oct 11.PMID: 17932417 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Mesenchymal stromal cells.

    Bernardo ME, Locatelli F, Fibbe WE.

    Ann N Y Acad Sci. 2009 Sep;1176:101-17. Review.PMID: 19796238 [PubMed - indexed for MEDLINE]Related articles

    9.

    Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.

    Vija L, Farge D, Gautier JF, Vexiau P, Dumitrache C, Bourgarit A, Verrecchia F, Larghero J.

    Diabetes Metab. 2009 Apr;35(2):85-93. Epub 2009 Feb 20. Review.PMID: 19230736 [PubMed - indexed for MEDLINE]Related articles

    10.

    Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.

    Nasef A, Mathieu N, Chapel A, Frick J, François S, Mazurier C, Boutarfa A, Bouchet S, Gorin NC, Thierry D, Fouillard L.

    Transplantation. 2007 Jul 27;84(2):231-7.PMID: 17667815 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Application of mesenchymal stem cell in immunotherapy--review]

    Liao LM, Han Q, Zhao CH.

    Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Feb;13(1):158-63. Review. Chinese. PMID: 15748459 [PubMed - indexed for MEDLINE]Related articles

    12.

    Bone marrow-derived mesenchymal stem cells for treatment of heart failure: is it all paracrine actions and immunomodulation?

    Mishra PK.

    J Cardiovasc Med (Hagerstown). 2008 Feb;9(2):122-8. Review.PMID: 18192802 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Regulation mechamion of mesenchymal stem cells to immunoeffector cells--review]

    Xie LN.

    Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Feb;14(1):183-6. Review. Chinese. PMID: 16584621 [PubMed - indexed for MEDLINE]Related articles

    14.

    Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes.

    Fiorina P, Jurewicz M, Augello A, Vergani A, Dada S, La Rosa S, Selig M, Godwin J, Law K, Placidi C, Smith RN, Capella C, Rodig S, Adra CN, Atkinson M, Sayegh MH, Abdi R.

    J Immunol. 2009 Jul 15;183(2):993-1004. Epub 2009 Jun 26.PMID: 19561093 [PubMed - indexed for MEDLINE]Related articles

    15.

    Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model.

    Inoue S, Popp FC, Koehl GE, Piso P, Schlitt HJ, Geissler EK, Dahlke MH.

    Transplantation. 2006 Jun 15;81(11):1589-95.PMID: 16770249 [PubMed - indexed for MEDLINE]Related articles

    16.

    Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool.

    García-Castro J, Trigueros C, Madrenas J, Pérez-Simón JA, Rodriguez R, Menendez P.

    J Cell Mol Med. 2008 Dec;12(6B):2552-65. Review.PMID: 19210755 [PubMed - indexed for MEDLINE]Related articles

    17.

    Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.

    Zheng ZH, Li XY, Ding J, Jia JF, Zhu P.

    Rheumatology (Oxford). 2008 Jan;47(1):22-30.PMID: 18077486 [PubMed - indexed for MEDLINE]Related articles

    18.

    Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration.

    Kode JA, Mukherjee S, Joglekar MV, Hardikar AA.

    Cytotherapy. 2009;11(4):377-91. Review.PMID: 19568970 [PubMed - indexed for MEDLINE]Related articles

    19.

    Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.

    Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Yañez AJ, Conget PA.

    Biol Blood Marrow Transplant. 2008 Jun;14(6):631-40. Epub 2008 Apr 14.PMID: 18489988 [PubMed - indexed for MEDLINE]Related articles

    20.

    Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms.

    Nasef A, Ashammakhi N, Fouillard L.

    Regen Med. 2008 Jul;3(4):531-46. Review.PMID: 18588475 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity